• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Cidara Therap(CDTX.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Jan7
Merck Completes Cash Tender Offer for Cidara Therapeutics
11:47
Nov25
Cidara Therapeutics Achieves Patient Enrollment Goal for ANCHOR Trial
10:06
Nov24
Merck & Co. Acquires Cidara Therapeutics for $9.2 Billion
03:52
Nov17
Merck Expects Over $5 Billion in Revenue from Cidara's Flu Drug
13:32
Merck Executives Indicate Cidara's Drug Can Go To Market Without CDC Approval
13:24
Nov15
Merck to Acquire Cidara Therapeutics for $9.2 Billion
10:58

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -83.23 M, EPS -3.0961

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.72 M, EPS -1.6541

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -23.48 M, EPS -1.6561

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ANPA
86.850
+258.88%
+62.650
NBY
19.160
+102.54%
+9.700
VLN
2.480
+58.97%
+0.920
GP
1.240
+51.04%
+0.419
ATGL
30.610
+46.96%
+9.781
OPAD
2.190
+44.08%
+0.670
VCIG
0.9601
+41.00%
+0.279
THH
29.470
+36.31%
+7.850
APLX
113.630
+35.44%
+29.730
ZNTL
3.740
+31.69%
+0.900
View More